Global Gene Therapy on Neurological Diseases Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Gene Therapy on Neurological Diseases Market Insights, Forecast to 2034

Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
Market Analysis and InsightsGlobal Gene Therapy on Neurological Diseases Market
Global Gene Therapy on Neurological Diseases market is expected to reach to US$ 5002 million in 2024, with a positive growth of %, compared with US$ 4347 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Gene Therapy on Neurological Diseases industry is evaluated to reach US$ 12190 million in 2029. The CAGR will be 16.0% during 2024 to 2029.
The Drug Based on Gene Therapy market is primarily driven by the revolutionary potential of gene therapy to address genetic disorders at their root cause, offering a new paradigm for treating previously incurable conditions. Gene therapy involves introducing genetic material into a patient's cells to correct or replace faulty genes, aiming to restore normal cellular function. The increasing understanding of the genetic basis of diseases, coupled with advancements in gene delivery methods and genome editing techniques, contributes to market growth. Moreover, the demonstrated benefits of gene therapy in providing targeted and long-lasting treatments, overcoming limitations of traditional pharmacological approaches, and offering hope to patients with rare genetic disorders further propel adoption. However, challenges include optimizing gene delivery efficiency, addressing potential immune responses, and ensuring the long-term safety and durability of gene-based treatments. Navigating regulatory pathways, conducting rigorous clinical trials, and addressing ethical considerations are ongoing concerns. The market's success relies on continuous research in genetic medicine, collaborations between biotechnology companies and research institutions, and comprehensive education on the benefits and potential challenges of using gene therapy-based drugs while addressing the evolving challenges associated with precision medicine and personalized treatments.
Report Covers
This report presents an overview of global Gene Therapy on Neurological Diseases market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Gene Therapy on Neurological Diseases market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report

By Company

Biogen
Novartis
Sarepta Therapeutics
Segment by Type
Viral Gene Therapy
Non-viral Gene Therapy

Segment by Application

Hospital
Clinic
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline

Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Gene Therapy on Neurological Diseases introduction, etc. Gene Therapy on Neurological Diseases Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Gene Therapy on Neurological Diseases
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Therapy on Neurological Diseases Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Viral Gene Therapy
1.2.3 Non-viral Gene Therapy
1.3 Market by Application
1.3.1 Global Gene Therapy on Neurological Diseases Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Therapy on Neurological Diseases Market Perspective (2018-2029)
2.2 Global Gene Therapy on Neurological Diseases Growth Trends by Region
2.2.1 Gene Therapy on Neurological Diseases Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Gene Therapy on Neurological Diseases Historic Market Size by Region (2018-2024)
2.2.3 Gene Therapy on Neurological Diseases Forecasted Market Size by Region (2024-2029)
2.3 Gene Therapy on Neurological Diseases Market Dynamics
2.3.1 Gene Therapy on Neurological Diseases Industry Trends
2.3.2 Gene Therapy on Neurological Diseases Market Drivers
2.3.3 Gene Therapy on Neurological Diseases Market Challenges
2.3.4 Gene Therapy on Neurological Diseases Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Gene Therapy on Neurological Diseases by Players
3.1.1 Global Gene Therapy on Neurological Diseases Revenue by Players (2018-2024)
3.1.2 Global Gene Therapy on Neurological Diseases Revenue Market Share by Players (2018-2024)
3.2 Global Gene Therapy on Neurological Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Gene Therapy on Neurological Diseases, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Gene Therapy on Neurological Diseases Market Concentration Ratio
3.4.1 Global Gene Therapy on Neurological Diseases Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy on Neurological Diseases Revenue in 2022
3.5 Global Key Players of Gene Therapy on Neurological Diseases Head office and Area Served
3.6 Global Key Players of Gene Therapy on Neurological Diseases, Product and Application
3.7 Global Key Players of Gene Therapy on Neurological Diseases, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Therapy on Neurological Diseases Breakdown Data by Type
4.1 Global Gene Therapy on Neurological Diseases Historic Market Size by Type (2018-2024)
4.2 Global Gene Therapy on Neurological Diseases Forecasted Market Size by Type (2024-2029)
5 Gene Therapy on Neurological Diseases Breakdown Data by Application
5.1 Global Gene Therapy on Neurological Diseases Historic Market Size by Application (2018-2024)
5.2 Global Gene Therapy on Neurological Diseases Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Gene Therapy on Neurological Diseases Market Size (2018-2029)
6.2 North America Gene Therapy on Neurological Diseases Market Size by Type
6.2.1 North America Gene Therapy on Neurological Diseases Market Size by Type (2018-2024)
6.2.2 North America Gene Therapy on Neurological Diseases Market Size by Type (2024-2029)
6.2.3 North America Gene Therapy on Neurological Diseases Market Share by Type (2018-2029)
6.3 North America Gene Therapy on Neurological Diseases Market Size by Application
6.3.1 North America Gene Therapy on Neurological Diseases Market Size by Application (2018-2024)
6.3.2 North America Gene Therapy on Neurological Diseases Market Size by Application (2024-2029)
6.3.3 North America Gene Therapy on Neurological Diseases Market Share by Application (2018-2029)
6.4 North America Gene Therapy on Neurological Diseases Market Size by Country
6.4.1 North America Gene Therapy on Neurological Diseases Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Gene Therapy on Neurological Diseases Market Size by Country (2018-2024)
6.4.3 North America Gene Therapy on Neurological Diseases Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Gene Therapy on Neurological Diseases Market Size (2018-2029)
7.2 Europe Gene Therapy on Neurological Diseases Market Size by Type
7.2.1 Europe Gene Therapy on Neurological Diseases Market Size by Type (2018-2024)
7.2.2 Europe Gene Therapy on Neurological Diseases Market Size by Type (2024-2029)
7.2.3 Europe Gene Therapy on Neurological Diseases Market Share by Type (2018-2029)
7.3 Europe Gene Therapy on Neurological Diseases Market Size by Application
7.3.1 Europe Gene Therapy on Neurological Diseases Market Size by Application (2018-2024)
7.3.2 Europe Gene Therapy on Neurological Diseases Market Size by Application (2024-2029)
7.3.3 Europe Gene Therapy on Neurological Diseases Market Share by Application (2018-2029)
7.4 Europe Gene Therapy on Neurological Diseases Market Size by Country
7.4.1 Europe Gene Therapy on Neurological Diseases Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Gene Therapy on Neurological Diseases Market Size by Country (2018-2024)
7.4.3 Europe Gene Therapy on Neurological Diseases Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Gene Therapy on Neurological Diseases Market Size (2018-2029)
8.2 China Gene Therapy on Neurological Diseases Market Size by Type
8.2.1 China Gene Therapy on Neurological Diseases Market Size by Type (2018-2024)
8.2.2 China Gene Therapy on Neurological Diseases Market Size by Type (2024-2029)
8.2.3 China Gene Therapy on Neurological Diseases Market Share by Type (2018-2029)
8.3 China Gene Therapy on Neurological Diseases Market Size by Application
8.3.1 China Gene Therapy on Neurological Diseases Market Size by Application (2018-2024)
8.3.2 China Gene Therapy on Neurological Diseases Market Size by Application (2024-2029)
8.3.3 China Gene Therapy on Neurological Diseases Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Gene Therapy on Neurological Diseases Market Size (2018-2029)
9.2 Asia Gene Therapy on Neurological Diseases Market Size by Type
9.2.1 Asia Gene Therapy on Neurological Diseases Market Size by Type (2018-2024)
9.2.2 Asia Gene Therapy on Neurological Diseases Market Size by Type (2024-2029)
9.2.3 Asia Gene Therapy on Neurological Diseases Market Share by Type (2018-2029)
9.3 Asia Gene Therapy on Neurological Diseases Market Size by Application
9.3.1 Asia Gene Therapy on Neurological Diseases Market Size by Application (2018-2024)
9.3.2 Asia Gene Therapy on Neurological Diseases Market Size by Application (2024-2029)
9.3.3 Asia Gene Therapy on Neurological Diseases Market Share by Application (2018-2029)
9.4 Asia Gene Therapy on Neurological Diseases Market Size by Region
9.4.1 Asia Gene Therapy on Neurological Diseases Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Gene Therapy on Neurological Diseases Market Size by Region (2018-2024)
9.4.3 Asia Gene Therapy on Neurological Diseases Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Gene Therapy on Neurological Diseases Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Gene Therapy on Neurological Diseases Market Size by Type
10.2.1 Middle East, Africa, and Latin America Gene Therapy on Neurological Diseases Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Gene Therapy on Neurological Diseases Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Gene Therapy on Neurological Diseases Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Gene Therapy on Neurological Diseases Market Size by Application
10.3.1 Middle East, Africa, and Latin America Gene Therapy on Neurological Diseases Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Gene Therapy on Neurological Diseases Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Gene Therapy on Neurological Diseases Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Gene Therapy on Neurological Diseases Market Size by Country
10.4.1 Middle East, Africa, and Latin America Gene Therapy on Neurological Diseases Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Gene Therapy on Neurological Diseases Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Gene Therapy on Neurological Diseases Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Biogen
11.1.1 Biogen Company Details
11.1.2 Biogen Business Overview
11.1.3 Biogen Gene Therapy on Neurological Diseases Introduction
11.1.4 Biogen Revenue in Gene Therapy on Neurological Diseases Business (2018-2024)
11.1.5 Biogen Recent Developments
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Gene Therapy on Neurological Diseases Introduction
11.2.4 Novartis Revenue in Gene Therapy on Neurological Diseases Business (2018-2024)
11.2.5 Novartis Recent Developments
11.3 Sarepta Therapeutics
11.3.1 Sarepta Therapeutics Company Details
11.3.2 Sarepta Therapeutics Business Overview
11.3.3 Sarepta Therapeutics Gene Therapy on Neurological Diseases Introduction
11.3.4 Sarepta Therapeutics Revenue in Gene Therapy on Neurological Diseases Business (2018-2024)
11.3.5 Sarepta Therapeutics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Gene Therapy on Neurological Diseases Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Viral Gene Therapy
Table 3. Key Players of Non-viral Gene Therapy
Table 4. Global Gene Therapy on Neurological Diseases Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global Gene Therapy on Neurological Diseases Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Gene Therapy on Neurological Diseases Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global Gene Therapy on Neurological Diseases Market Share by Region (2018-2024)
Table 8. Global Gene Therapy on Neurological Diseases Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Gene Therapy on Neurological Diseases Market Share by Region (2024-2029)
Table 10. Gene Therapy on Neurological Diseases Market Trends
Table 11. Gene Therapy on Neurological Diseases Market Drivers
Table 12. Gene Therapy on Neurological Diseases Market Challenges
Table 13. Gene Therapy on Neurological Diseases Market Restraints
Table 14. Global Gene Therapy on Neurological Diseases Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global Gene Therapy on Neurological Diseases Revenue Share by Players (2018-2024)
Table 16. Global Top Gene Therapy on Neurological Diseases by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy on Neurological Diseases as of 2022)
Table 17. Global Gene Therapy on Neurological Diseases Industry Ranking 2021 VS 2022 VS 2024
Table 18. Global 5 Largest Players Market Share by Gene Therapy on Neurological Diseases Revenue (CR5 and HHI) & (2018-2024)
Table 19. Global Key Players of Gene Therapy on Neurological Diseases, Headquarters and Area Served
Table 20. Global Key Players of Gene Therapy on Neurological Diseases, Product and Application
Table 21. Global Key Players of Gene Therapy on Neurological Diseases, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Gene Therapy on Neurological Diseases Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global Gene Therapy on Neurological Diseases Revenue Market Share by Type (2018-2024)
Table 25. Global Gene Therapy on Neurological Diseases Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Gene Therapy on Neurological Diseases Revenue Market Share by Type (2024-2029)
Table 27. Global Gene Therapy on Neurological Diseases Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global Gene Therapy on Neurological Diseases Revenue Share by Application (2018-2024)
Table 29. Global Gene Therapy on Neurological Diseases Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Gene Therapy on Neurological Diseases Revenue Share by Application (2024-2029)
Table 31. North America Gene Therapy on Neurological Diseases Market Size by Type (2018-2024) & (US$ Million)
Table 32. North America Gene Therapy on Neurological Diseases Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America Gene Therapy on Neurological Diseases Market Size by Application (2018-2024) & (US$ Million)
Table 34. North America Gene Therapy on Neurological Diseases Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America Gene Therapy on Neurological Diseases Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Gene Therapy on Neurological Diseases Market Size by Country (2018-2024) & (US$ Million)
Table 37. North America Gene Therapy on Neurological Diseases Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Gene Therapy on Neurological Diseases Market Size by Type (2018-2024) & (US$ Million)
Table 39. Europe Gene Therapy on Neurological Diseases Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe Gene Therapy on Neurological Diseases Market Size by Application (2018-2024) & (US$ Million)
Table 41. Europe Gene Therapy on Neurological Diseases Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe Gene Therapy on Neurological Diseases Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe Gene Therapy on Neurological Diseases Market Size by Country (2018-2024) & (US$ Million)
Table 44. Europe Gene Therapy on Neurological Diseases Market Size by Country (2024-2029) & (US$ Million)
Table 45. China Gene Therapy on Neurological Diseases Market Size by Type (2018-2024) & (US$ Million)
Table 46. China Gene Therapy on Neurological Diseases Market Size by Type (2024-2029) & (US$ Million)
Table 47. China Gene Therapy on Neurological Diseases Market Size by Application (2018-2024) & (US$ Million)
Table 48. China Gene Therapy on Neurological Diseases Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia Gene Therapy on Neurological Diseases Market Size by Type (2018-2024) & (US$ Million)
Table 50. Asia Gene Therapy on Neurological Diseases Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia Gene Therapy on Neurological Diseases Market Size by Application (2018-2024) & (US$ Million)
Table 52. Asia Gene Therapy on Neurological Diseases Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia Gene Therapy on Neurological Diseases Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia Gene Therapy on Neurological Diseases Market Size by Region (2018-2024) & (US$ Million)
Table 55. Asia Gene Therapy on Neurological Diseases Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Gene Therapy on Neurological Diseases Market Size by Type (2018-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Gene Therapy on Neurological Diseases Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Gene Therapy on Neurological Diseases Market Size by Application (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Gene Therapy on Neurological Diseases Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Gene Therapy on Neurological Diseases Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America Gene Therapy on Neurological Diseases Market Size by Country (2018-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Gene Therapy on Neurological Diseases Market Size by Country (2024-2029) & (US$ Million)
Table 63. Biogen Company Details
Table 64. Biogen Business Overview
Table 65. Biogen Gene Therapy on Neurological Diseases Product
Table 66. Biogen Revenue in Gene Therapy on Neurological Diseases Business (2018-2024) & (US$ Million)
Table 67. Biogen Recent Developments
Table 68. Novartis Company Details
Table 69. Novartis Business Overview
Table 70. Novartis Gene Therapy on Neurological Diseases Product
Table 71. Novartis Revenue in Gene Therapy on Neurological Diseases Business (2018-2024) & (US$ Million)
Table 72. Novartis Recent Developments
Table 73. Sarepta Therapeutics Company Details
Table 74. Sarepta Therapeutics Business Overview
Table 75. Sarepta Therapeutics Gene Therapy on Neurological Diseases Product
Table 76. Sarepta Therapeutics Revenue in Gene Therapy on Neurological Diseases Business (2018-2024) & (US$ Million)
Table 77. Sarepta Therapeutics Recent Developments
Table 78. Research Programs/Design for This Report
Table 79. Key Data Information from Secondary Sources
Table 80. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gene Therapy on Neurological Diseases Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Gene Therapy on Neurological Diseases Market Share by Type: 2022 VS 2029
Figure 3. Viral Gene Therapy Features
Figure 4. Non-viral Gene Therapy Features
Figure 5. Global Gene Therapy on Neurological Diseases Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global Gene Therapy on Neurological Diseases Market Share by Application: 2022 VS 2029
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Other Case Studies
Figure 10. Gene Therapy on Neurological Diseases Report Years Considered
Figure 11. Global Gene Therapy on Neurological Diseases Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Gene Therapy on Neurological Diseases Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Gene Therapy on Neurological Diseases Market Share by Region: 2022 VS 2029
Figure 14. Global Gene Therapy on Neurological Diseases Market Share by Players in 2022
Figure 15. Global Top Gene Therapy on Neurological Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy on Neurological Diseases as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Gene Therapy on Neurological Diseases Revenue in 2022
Figure 17. North America Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Gene Therapy on Neurological Diseases Market Share by Type (2018-2029)
Figure 19. North America Gene Therapy on Neurological Diseases Market Share by Application (2018-2029)
Figure 20. North America Gene Therapy on Neurological Diseases Market Share by Country (2018-2029)
Figure 21. United States Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Gene Therapy on Neurological Diseases Market Size YoY (2018-2029) & (US$ Million)
Figure 24. Europe Gene Therapy on Neurological Diseases Market Share by Type (2018-2029)
Figure 25. Europe Gene Therapy on Neurological Diseases Market Share by Application (2018-2029)
Figure 26. Europe Gene Therapy on Neurological Diseases Market Share by Country (2018-2029)
Figure 27. Germany Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. China Gene Therapy on Neurological Diseases Market Size YoY (2018-2029) & (US$ Million)
Figure 34. China Gene Therapy on Neurological Diseases Market Share by Type (2018-2029)
Figure 35. China Gene Therapy on Neurological Diseases Market Share by Application (2018-2029)
Figure 36. Asia Gene Therapy on Neurological Diseases Market Size YoY (2018-2029) & (US$ Million)
Figure 37. Asia Gene Therapy on Neurological Diseases Market Share by Type (2018-2029)
Figure 38. Asia Gene Therapy on Neurological Diseases Market Share by Application (2018-2029)
Figure 39. Asia Gene Therapy on Neurological Diseases Market Share by Region (2018-2029)
Figure 40. Japan Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. South Korea Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. China Taiwan Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Southeast Asia Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. India Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Australia Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Gene Therapy on Neurological Diseases Market Size YoY (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Gene Therapy on Neurological Diseases Market Share by Type (2018-2029)
Figure 48. Middle East, Africa, and Latin America Gene Therapy on Neurological Diseases Market Share by Application (2018-2029)
Figure 49. Middle East, Africa, and Latin America Gene Therapy on Neurological Diseases Market Share by Country (2018-2029)
Figure 50. Brazil Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Mexico Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Turkey Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Israel Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. GCC Countries Gene Therapy on Neurological Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Biogen Revenue Growth Rate in Gene Therapy on Neurological Diseases Business (2018-2024)
Figure 57. Novartis Revenue Growth Rate in Gene Therapy on Neurological Diseases Business (2018-2024)
Figure 58. Sarepta Therapeutics Revenue Growth Rate in Gene Therapy on Neurological Diseases Business (2018-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed

Global Gene Therapy on Neurological Diseases Market Insights, Forecast to 2034

Global Gene Therapy on Neurological Diseases Market Insights, Forecast to 2034

By Company

Segment by Application

Chapter Outline

Table of Content

List of Figure

Select User License

$4200 Single Licence

$6000 Enterprise Licence

$9100 Corporate Licence

Note : All prices in USD

FAQ'S

User License?

Delivery Time?

How do I place an order?

What is the Payment Options?

Is there a discount for multiple purchases?

Mode of Report Delivery?

Top Industries